×
S&P 500   3,805.92 (-0.51%)
DOW   30,765.65 (-1.07%)
QQQ   283.58 (+0.51%)
AAPL   140.25 (+0.95%)
MSFT   259.61 (+0.01%)
META   165.59 (+3.47%)
GOOGL   2,241.97 (+3.09%)
AMZN   113.01 (+3.15%)
TSLA   688.40 (+0.97%)
NVDA   147.91 (+1.85%)
NIO   21.81 (+2.11%)
BABA   116.91 (+0.78%)
AMD   74.31 (+0.87%)
MU   55.86 (+4.12%)
CGC   2.65 (-5.69%)
T   20.96 (-1.64%)
GE   61.11 (-3.82%)
F   11.07 (-2.21%)
DIS   96.32 (+0.19%)
AMC   12.59 (-6.95%)
PFE   51.07 (-2.37%)
PYPL   73.63 (+3.12%)
NFLX   183.21 (+1.81%)
S&P 500   3,805.92 (-0.51%)
DOW   30,765.65 (-1.07%)
QQQ   283.58 (+0.51%)
AAPL   140.25 (+0.95%)
MSFT   259.61 (+0.01%)
META   165.59 (+3.47%)
GOOGL   2,241.97 (+3.09%)
AMZN   113.01 (+3.15%)
TSLA   688.40 (+0.97%)
NVDA   147.91 (+1.85%)
NIO   21.81 (+2.11%)
BABA   116.91 (+0.78%)
AMD   74.31 (+0.87%)
MU   55.86 (+4.12%)
CGC   2.65 (-5.69%)
T   20.96 (-1.64%)
GE   61.11 (-3.82%)
F   11.07 (-2.21%)
DIS   96.32 (+0.19%)
AMC   12.59 (-6.95%)
PFE   51.07 (-2.37%)
PYPL   73.63 (+3.12%)
NFLX   183.21 (+1.81%)
S&P 500   3,805.92 (-0.51%)
DOW   30,765.65 (-1.07%)
QQQ   283.58 (+0.51%)
AAPL   140.25 (+0.95%)
MSFT   259.61 (+0.01%)
META   165.59 (+3.47%)
GOOGL   2,241.97 (+3.09%)
AMZN   113.01 (+3.15%)
TSLA   688.40 (+0.97%)
NVDA   147.91 (+1.85%)
NIO   21.81 (+2.11%)
BABA   116.91 (+0.78%)
AMD   74.31 (+0.87%)
MU   55.86 (+4.12%)
CGC   2.65 (-5.69%)
T   20.96 (-1.64%)
GE   61.11 (-3.82%)
F   11.07 (-2.21%)
DIS   96.32 (+0.19%)
AMC   12.59 (-6.95%)
PFE   51.07 (-2.37%)
PYPL   73.63 (+3.12%)
NFLX   183.21 (+1.81%)
S&P 500   3,805.92 (-0.51%)
DOW   30,765.65 (-1.07%)
QQQ   283.58 (+0.51%)
AAPL   140.25 (+0.95%)
MSFT   259.61 (+0.01%)
META   165.59 (+3.47%)
GOOGL   2,241.97 (+3.09%)
AMZN   113.01 (+3.15%)
TSLA   688.40 (+0.97%)
NVDA   147.91 (+1.85%)
NIO   21.81 (+2.11%)
BABA   116.91 (+0.78%)
AMD   74.31 (+0.87%)
MU   55.86 (+4.12%)
CGC   2.65 (-5.69%)
T   20.96 (-1.64%)
GE   61.11 (-3.82%)
F   11.07 (-2.21%)
DIS   96.32 (+0.19%)
AMC   12.59 (-6.95%)
PFE   51.07 (-2.37%)
PYPL   73.63 (+3.12%)
NFLX   183.21 (+1.81%)
NASDAQ:FTRP

Field Trip Health Earnings Date, Estimates & Call Transcripts (2022)

$0.84
0.00 (-0.01%)
(As of 07/1/2022 08:00 PM ET)
Add
Compare
Today's Range
$0.84
$0.84
50-Day Range
$0.76
$1.20
52-Week Range
$0.71
$6.74
Volume
10,400 shs
Average Volume
52,009 shs
Market Capitalization
$48.85 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$17.75
Skip Charts & View Estimated and Actual Earnings Data

FTRP Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

FTRP Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Field Trip Health Earnings Estimates

Current Year EPS Consensus Estimate: $-0.55 EPS
Next Year EPS Consensus Estimate: $-0.65 EPS

FTRP Earnings Date and Information

Field Trip Health has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 15th, 2022 based off prior year's report dates.

Field Trip Health Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/15/2022
(Estimated)
        
2/15/2022Q3 2022($0.19)($0.21)($0.02)($0.21)$1.35 million$1.09 million
11/15/20219/30/2021($0.15)($0.18)($0.03)($0.18)$1.10 million$0.72 million    
8/16/2021Q1 2022($0.16)($0.16)($0.14)$0.71 million












Field Trip Health Earnings - Frequently Asked Questions

When is Field Trip Health's earnings date?

Field Trip Health has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 15th, 2022 based off last year's report dates. Learn more on FTRP's earnings history.

How much revenue does Field Trip Health generate each year?

Field Trip Health (NASDAQ:FTRP) has a recorded annual revenue of $3.88 million.

How much profit does Field Trip Health generate each year?

Field Trip Health (NASDAQ:FTRP) has a recorded net income of -$43.63 million. FTRP has generated -$0.77 earnings per share over the last four quarters.

What is Field Trip Health's EPS forecast for next year?

Field Trip Health's earnings are expected to decrease from ($0.55) per share to ($0.65) per share in the next year.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:FTRP) was last updated on 7/5/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.